DelveInsight Blog
Antibody-Drug Conjugate: The Smart Biological Bomb
Antibody-drug conjugate (ADCs) is a new emerging class of highly potent pharmaceutical drugs, which is a great combination of chemotherapy and immunotherapy. Over the past couple of decades, antibody-drug conjugates have revolutionized the field of cancer chemotherapy. ADCs are composed of 3 parts: an antibody drug...
Find MoreSign Up & Stay Informed
Penetrative insights and rich analysis of Pharma, Biotech and MedTech space.
Join Up Now!Editor's Pick
Newsletter/Whitepaper
-Agonist.png "Toll-like Receptors Agonist")
Sign up For Newsletters
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
Recent Article
ASCO Conference 2022
The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.
